Instituto Brasil de Pesquisa Clínica - IBPClin
Instituto Brasil de Pesquisa Clínica - IBPClin
R. da Glória, 344 - Glória, Rio de Janeiro - RJ, 20241-180
Select an option
I am a doctor
I am a sponsor
Our team
Medical staff
Luis Augusto Tavares Russo
Cristiane Scaf
Mariana Martins P.
Gabriela Beserra
Carlos Alfredo Lopes Cardoso e Souza
Mariana Martins
Raquel Sousa
Fabio Antonio Tuche
Mellina Pimenta
Jayndra Moura
Monik Pizzini
Michele de Sousa Rodrigues
Patricia Andrade Andrade
Sarah Lima de Araujo
Alexandre Francisco
Joselita Maria Bodart
Ana Claudia Melazzi
Renata Alexandra Calixto Pinheiro
Nathalia Costa Ferreli
Lais Santos
Larissa Lima
Milene Amorim
Priscila Brandao
Fabiana Ribeiro
Open studies
Cardiovascular disease
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) - ATTAIN-Outcomes - Eli Lilly and CompanySee more
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity - MARITIME-CV - AmgenSee more
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) - MOVE-Lp(a) - Eli Lilly and CompanySee more
Obesity
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity - MARITIME-HF - AmgenSee more
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity - MARITIME-CV - AmgenSee more
Renal disease
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) - ATTAIN-Outcomes - Eli Lilly and CompanySee more
Heart failure
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity - MARITIME-HF - AmgenSee more
Dermatitis
A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis - READY-AD - Janssen Research & Development, LLCSee more
Elevated Lipoprotein A
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) - MOVE-Lp(a) - Eli Lilly and CompanySee more
Hyperlipidemia
A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037) - MK-0616-037 - Merck Sharp & Dohme LLCSee more
